CLINICAL_TRIALS
trial_result
· 2022-05-11
Clinical Trial Update: Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS [Phase 3]
Summary
Phase 3 clinical trial evaluating pain and quality of life after mediastinal tumor resection using subxiphoid and intercostal VATS, status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lei Jiang | Conditions: Mediastinal Neoplasms, Thoracic Neoplasm | Phase 3 | Status: UNKNOWN